Home › Canaccord Genuity Reaffirms "Buy" Rating for Regeneron Pharmaceuticals
 

Keywords :   


Canaccord Genuity Reaffirms "Buy" Rating for Regeneron Pharmaceuticals

2015-05-26 01:13:12| Biotech - Topix.net

's stock had its "buy" rating reaffirmed by investment analysts at Canaccord Genuity in a note issued to investors on Thursday. They currently have a $460.00 price target on the biopharmaceutical company's stock.

Tags: buy rating pharmaceuticals reaffirms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Tropical Storm Joyce Wind Speed Probabilities Number 7
29.09Tropical Storm Joyce Forecast Discussion Number 7
More »